These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats. Trommer BL; Pasternak JF Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746 [TBL] [Abstract][Full Text] [Related]
46. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801. Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964 [TBL] [Abstract][Full Text] [Related]
47. Effect of 2-amino-7-phosphonoheptanoic acid (APH) on seizure susceptibility in the prepubescent and mature rat. Holmes GL; Thompson JL; Carl GF; Gallagher BS; Hoy J; McLaughlin M Epilepsy Res; 1990 Mar; 5(2):125-30. PubMed ID: 2158439 [TBL] [Abstract][Full Text] [Related]
48. Epileptiform bursts elicited in CA3 hippocampal neurons by a variety of convulsants are not blocked by N-methyl-D-aspartate antagonists. Neuman R; Cherubini E; Ben-Ari Y Brain Res; 1988 Sep; 459(2):265-74. PubMed ID: 2902900 [TBL] [Abstract][Full Text] [Related]
49. Evidence that NMDA receptors contribute to synaptic function in the guinea pig medial vestibular nucleus. Smith PF; Darlington CL; Hubbard JI Brain Res; 1990 Apr; 513(1):149-51. PubMed ID: 2161695 [TBL] [Abstract][Full Text] [Related]
50. NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine. Fragoso-Veloz J; Tapia R Eur J Pharmacol; 1992 Oct; 221(2-3):275-80. PubMed ID: 1426006 [TBL] [Abstract][Full Text] [Related]
51. Mode of blockade by MK-801 of N-methyl-D-aspartate-induced increase in intracellular Ca2+ in cultured mouse hippocampal neurons. Yuzaki M; Miyawaki A; Akita K; Kudo Y; Ogura A; Ino H; Mikoshiba K Brain Res; 1990 May; 517(1-2):51-6. PubMed ID: 2165437 [TBL] [Abstract][Full Text] [Related]
52. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats. Tang AH; Ho PM Eur J Pharmacol; 1988 Jun; 151(1):143-6. PubMed ID: 3046954 [TBL] [Abstract][Full Text] [Related]
56. Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline. Gold LH; Balster RL Eur J Pharmacol; 1993 Jan; 230(3):285-92. PubMed ID: 8095022 [TBL] [Abstract][Full Text] [Related]
57. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures. Holmes KH; Bilkey DK; Laverty R; Goddard GV Brain Res; 1990 Jan; 506(2):227-35. PubMed ID: 1967965 [TBL] [Abstract][Full Text] [Related]
58. A role for N-methyl-D-aspartate (NMDA) receptors in the control of LH secretion and initiation of female puberty. Urbanski HF; Ojeda SR Endocrinology; 1990 Mar; 126(3):1774-6. PubMed ID: 1968384 [TBL] [Abstract][Full Text] [Related]
59. In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. Wood PL; Emmett MR; Rao TS; Mick S; Cler J; Iyengar S J Neurochem; 1989 Sep; 53(3):979-81. PubMed ID: 2547911 [TBL] [Abstract][Full Text] [Related]
60. An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site. Williams K; Pullan LM; Romano C; Powel RJ; Salama AI; Molinoff PB J Pharmacol Exp Ther; 1992 Aug; 262(2):539-44. PubMed ID: 1354252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]